At the Special Meeting of Stockholders held on December 5, 2025, the Company's stockholders approved a reverse stock split of Co-Dx common stock at a ratio of not less than 1-for-2 and not more than 1 ...

NEW YORK, Dec. 30, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, ...

RYVYL (RVYL) announced that its board of directors has approved a 1-for-35 reverse stock split of its common stock. The primary objective of the reverse split is to increase the per-share trading ...

New Haven-based Rallybio Corp. is asking shareholders to approve a reverse stock split as the clinical-stage biotechnology company works to regain compliance with Nasdaq’s minimum share-price rules ...

SALT LAKE CITY, Dec. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...

(RTTNews) - Adicet Bio (ACET) said its board has approved a one-for-16 reverse stock split of the company's common stock as part of efforts to regain compliance with Nasdaq's minimum bid price ...

(RTTNews) - Aptevo Therapeutics Inc. (APVO), a clinical-stage biotechnology company, is scheduled to implement a 1-for-18 reverse stock split of its outstanding shares of common stock on December 29, ...

Shareholders have approved a reverse stock split plan, with the board deciding on a 1-for-3,000 reverse split to be immediately followed by a 3,000-for-1 forward split. This move is set to take effect ...

Aptevo Therapeutics Inc. (NASDAQ:APVO) implemented a 1-for-18 reverse stock split of its common stock, effective at 5:01 p.m. Eastern Time on Monday. This action follows approval by shareholders at a ...

The reverse split will take effect at 12:01 a.m. Eastern Time on December 30, 2025, with the stock beginning to trade on a split-adjusted basis when markets open that day. The move will reduce ...

The MarketWatch News Department was not involved in the creation of this content. SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage ...